AVALO THERAPEUTICS, INC. Operating Lease Liability
AVALO THERAPEUTICS, INC. (AVTX) had Operating Lease Liability of $242.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability $242.00K.
- 2026-03-31: Operating Lease, Liability $328.00K.
- 2025-12-31: Operating Lease, Liability $427.00K.
- 2025-09-30: Operating Lease, Liability $555.00K.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2026-06-30 | $242.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $328.00K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $427.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $555.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $679.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $801.00K 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $918.00K 10-K · filed 2026-03-23 | |
| 2024-09-30 | $1.63M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $1.73M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $1.83M 10-Q/A · filed 2024-07-11 | |
| 2023-12-31 | $1.90M 10-K · filed 2025-03-20 | |
| 2023-09-30 | $1.99M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $2.08M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $2.16M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $2.24M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $2.32M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $2.39M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $2.47M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $2.50M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $1.20M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $1.29M 10-Q · filed 2021-08-02 | |
| 2021-03-31 | $1.38M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $1.46M 10-K · filed 2022-03-02 | $1.46M 10-K · filed 2021-03-08 |
| 2020-09-30 | $1.54M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $1.62M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $1.26M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $1.27M 10-K · filed 2021-03-08 | |
| 2019-09-30 | $1.24M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $1.21M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $1.21M 10-Q · filed 2019-08-08 | $1.19M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |